Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Dec;79(6):470–471. doi: 10.1136/adc.79.6.470

Varicella: to vaccinate or not to vaccinate?

A GERSHON 1
PMCID: PMC1717764  PMID: 10210988

Full Text

The Full Text of this article is available as a PDF (75.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano Y., Suga S., Yoshikawa T., Kobayashi I., Yazaki T., Shibata M., Tsuzuki K., Ito S. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994 Oct;94(4 Pt 1):524–526. [PubMed] [Google Scholar]
  2. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis. 1996 Nov;174 (Suppl 3):S310–S313. doi: 10.1093/infdis/174.supplement_3.s310. [DOI] [PubMed] [Google Scholar]
  3. Bernardini S., Semama D. S., Huet F., Sgro C., Gouyon J. B. Effects of cisapride on QTc interval in neonates. Arch Dis Child Fetal Neonatal Ed. 1997 Nov;77(3):F241–F243. doi: 10.1136/fn.77.3.f241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bindl L., Buderus S., Ramirez M., Kirchhoff P., Lentze M. J. Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children. Intensive Care Med. 1996 Sep;22(9):977–980. doi: 10.1007/BF02044127. [DOI] [PubMed] [Google Scholar]
  5. Broyer M., Tete M. J., Guest G., Gagnadoux M. F., Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics. 1997 Jan;99(1):35–39. doi: 10.1542/peds.99.1.35. [DOI] [PubMed] [Google Scholar]
  6. Cucchiara S., Staiano A., Boccieri A., De Stefano M., Capozzi C., Manzi G., Camerlingo F., Paone F. M. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut. 1990 Jan;31(1):21–25. doi: 10.1136/gut.31.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cucchiara S., Staiano A., Capozzi C., Di Lorenzo C., Boccieri A., Auricchio S. Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child. 1987 May;62(5):454–457. doi: 10.1136/adc.62.5.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dab I., Malfroot A. Gastroesophageal reflux: a primary defect in cystic fibrosis? Scand J Gastroenterol Suppl. 1988;143:125–131. doi: 10.3109/00365528809090232. [DOI] [PubMed] [Google Scholar]
  9. Davies H. D., McGeer A., Schwartz B., Green K., Cann D., Simor A. E., Low D. E. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996 Aug 22;335(8):547–554. doi: 10.1056/NEJM199608223350803. [DOI] [PubMed] [Google Scholar]
  10. Di Lorenzo C., Reddy S. N., Villanueva-Meyer J., Mena I., Martin S., Hyman P. E. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial. Gastroenterology. 1991 Dec;101(6):1564–1570. doi: 10.1016/0016-5085(91)90393-y. [DOI] [PubMed] [Google Scholar]
  11. Dworsky M., Whitley R., Alford C. Herpes zoster in early infancy. Am J Dis Child. 1980 Jun;134(6):618–619. doi: 10.1001/archpedi.1980.02130180074021. [DOI] [PubMed] [Google Scholar]
  12. Gershon A. A. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis. 1995;10:93–124. [PubMed] [Google Scholar]
  13. Gil Vernet J. M., Casasa J. M., Boix Ochoa J., Salas A., Broto J., Marhuenda C. Dismotilidad intestinal-pseudoobstrucción. Cir Pediatr. 1992 Apr;5(2):87–95. [PubMed] [Google Scholar]
  14. Halloran M. E. Epidemiologic effects of varicella vaccination. Infect Dis Clin North Am. 1996 Sep;10(3):631–655. doi: 10.1016/s0891-5520(05)70318-4. [DOI] [PubMed] [Google Scholar]
  15. Hardy I., Gershon A. A., Steinberg S. P., LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991 Nov 28;325(22):1545–1550. doi: 10.1056/NEJM199111283252204. [DOI] [PubMed] [Google Scholar]
  16. Hedner T., Hedner J., Gelin-Friberg A., Huang M. L., Van de Poel S., Woestenborghs R., Van Peer A., Heykants J. Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers. Eur J Clin Pharmacol. 1990;38(6):629–631. doi: 10.1007/BF00278595. [DOI] [PubMed] [Google Scholar]
  17. Hill S. L., Evangelista J. K., Pizzi A. M., Mobassaleh M., Fulton D. R., Berul C. I. Proarrhythmia associated with cisapride in children. Pediatrics. 1998 Jun;101(6):1053–1056. doi: 10.1542/peds.101.6.1053. [DOI] [PubMed] [Google Scholar]
  18. Hyman P. E., Di Lorenzo C., McAdams L., Flores A. F., Tomomasa T., Garvey T. Q., 3rd Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol. 1993 Jun;88(6):832–836. [PubMed] [Google Scholar]
  19. Iacono G., Carroccio A., Montalto G., Cavataio F., Lorello D., Soresi M., Kazmierska I., Balsamo V. Valutazione dell'efficacia della cisapride nel trattamento del reflusso gastro-esofageo. Minerva Pediatr. 1992 Dec;44(12):613–616. [PubMed] [Google Scholar]
  20. Jaeggi A., Zurbruegg R. P., Aebi C. Complications of varicella in a defined central European population. Arch Dis Child. 1998 Dec;79(6):472–477. doi: 10.1136/adc.79.6.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnson C. E., Stancin T., Fattlar D., Rome L. P., Kumar M. L. A long-term prospective study of varicella vaccine in healthy children. Pediatrics. 1997 Nov;100(5):761–766. doi: 10.1542/peds.100.5.761. [DOI] [PubMed] [Google Scholar]
  22. Lander A., Redkar R., Nicholls G., Lawson A., Choudhury S. R., Corkery J. J., Gornall P., Buick R. G., Booth I. W. Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997 Sep;77(2):F119–F122. doi: 10.1136/fn.77.2.f119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Levine A., Fogelman R., Sirota L., Zangen Z., Shamir R., Dinari G. QT interval in children and infants receiving cisapride. Pediatrics. 1998 Mar;101(3):E9–E9. doi: 10.1542/peds.101.3.e9. [DOI] [PubMed] [Google Scholar]
  24. Lim Y. J., Chew F. T., Tan A. Y., Lee B. W. Risk factors for breakthrough varicella in healthy children. Arch Dis Child. 1998 Dec;79(6):478–480. doi: 10.1136/adc.79.6.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lupoglazoff J. M., Bedu A., Faure C., Denjoy I., Casasoprana A., Cézard J. P., Aujard Y. Allongement de l'espace QT sous cisapride chez le nouveau-né et le nourrisson. Arch Pediatr. 1997 Jun;4(6):509–514. doi: 10.1016/s0929-693x(97)87568-9. [DOI] [PubMed] [Google Scholar]
  26. Malfroot A., Dab I. New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. Arch Dis Child. 1991 Nov;66(11):1339–1345. doi: 10.1136/adc.66.11.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Malfroot A., Vandenplas Y., Verlinden M., Piepsz A., Dab I. Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children. Pediatr Pulmonol. 1987 Jul-Aug;3(4):208–213. doi: 10.1002/ppul.1950030403. [DOI] [PubMed] [Google Scholar]
  28. Melis K., Janssens G. Long-term use of cisapride (Prepulsid) in premature neonates. Acta Gastroenterol Belg. 1990 Jul-Aug;53(4):372–375. [PubMed] [Google Scholar]
  29. Murray R. D., Li B. U., McClung H. J., Heitlinger L., Rehm D. Cisapride for intractable constipation in children: observations from an open trial. J Pediatr Gastroenterol Nutr. 1990 Nov;11(4):503–508. doi: 10.1097/00005176-199011000-00010. [DOI] [PubMed] [Google Scholar]
  30. Nurko S., Garcia-Aranda J. A., Guerrero V. Y., Worona L. B. Treatment of intractable constipation in children: experience with cisapride. J Pediatr Gastroenterol Nutr. 1996 Jan;22(1):38–44. doi: 10.1097/00005176-199601000-00006. [DOI] [PubMed] [Google Scholar]
  31. Rode H., Stunden R. J., Millar A. J., Cywes S. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide. J Pediatr Surg. 1987 Oct;22(10):931–934. doi: 10.1016/s0022-3468(87)80592-4. [DOI] [PubMed] [Google Scholar]
  32. Saye Z. N., Forget P. P., Geubelle F. Effect of cisapride on gastroesophageal reflux in children with chronic bronchopulmonary disease: a double-blind cross-over pH-monitoring study. Pediatr Pulmonol. 1987 Jan-Feb;3(1):8–12. doi: 10.1002/ppul.1950030105. [DOI] [PubMed] [Google Scholar]
  33. Saye Z., Forget P. P. Effect of cisapride on esophageal pH monitoring in children with reflux-associated bronchopulmonary disease. J Pediatr Gastroenterol Nutr. 1989 Apr;8(3):327–332. doi: 10.1097/00005176-198904000-00011. [DOI] [PubMed] [Google Scholar]
  34. Schwartz P. J., Stramba-Badiale M., Segantini A., Austoni P., Bosi G., Giorgetti R., Grancini F., Marni E. D., Perticone F., Rosti D. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998 Jun 11;338(24):1709–1714. doi: 10.1056/NEJM199806113382401. [DOI] [PubMed] [Google Scholar]
  35. Staiano A., Cucchiara S., Andreotti M. R., Minella R., Manzi G. Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci. 1991 Jun;36(6):733–736. doi: 10.1007/BF01311229. [DOI] [PubMed] [Google Scholar]
  36. Staiano A., Del Giudice E., Simeone D., Miele E., Marino A. Cisapride in neurologically impaired children with chronic constipation. Dig Dis Sci. 1996 May;41(5):870–874. doi: 10.1007/BF02091525. [DOI] [PubMed] [Google Scholar]
  37. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974 Nov 30;2(7892):1288–1290. doi: 10.1016/s0140-6736(74)90144-5. [DOI] [PubMed] [Google Scholar]
  38. Terada K., Kawano S., Yoshihiro K., Morita T. Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy. J Infect Dis. 1994 Mar;169(3):650–652. doi: 10.1093/infdis/169.3.650. [DOI] [PubMed] [Google Scholar]
  39. Valdes L., Champel V., Olivier C., Jonville-Bera A. P., Autret E. Malaise avec allongement de l'espace QT chez un nourrisson de 39 jours traité par cisapride. Arch Pediatr. 1997 Jun;4(6):535–537. doi: 10.1016/s0929-693x(97)87572-0. [DOI] [PubMed] [Google Scholar]
  40. Van Eygen M., Van Ravensteyn H. Effect of cisapride on excessive regurgitation in infants. Clin Ther. 1989 Sep-Oct;11(5):669–677. [PubMed] [Google Scholar]
  41. Vandenplas Y., Ashkenazi A., Belli D., Boige N., Bouquet J., Cadranel S., Cezard J. P., Cucchiara S., Dupont C., Geboes K. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN). Eur J Pediatr. 1993 Sep;152(9):704–711. doi: 10.1007/BF01953980. [DOI] [PubMed] [Google Scholar]
  42. Vandenplas Y., de Roy C., Sacre L. Cisapride decreases prolonged episodes of reflux in infants. J Pediatr Gastroenterol Nutr. 1991 Jan;12(1):44–47. doi: 10.1097/00005176-199101000-00009. [DOI] [PubMed] [Google Scholar]
  43. Varis T., Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis. 1996 Nov;174 (Suppl 3):S330–S334. doi: 10.1093/infdis/174.supplement_3.s330. [DOI] [PubMed] [Google Scholar]
  44. Weibel R. E., Neff B. J., Kuter B. J., Guess H. A., Rothenberger C. A., Fitzgerald A. J., Connor K. A., McLean A. A., Hilleman M. R., Buynak E. B. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984 May 31;310(22):1409–1415. doi: 10.1056/NEJM198405313102201. [DOI] [PubMed] [Google Scholar]
  45. White C. J. Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am. 1996 Sep;10(3):595–608. doi: 10.1016/s0891-5520(05)70315-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES